These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 8018762)

  • 1. Inadequate erythropoietin response to anemia: definition and clinical relevance.
    Barosi G
    Ann Hematol; 1994 May; 68(5):215-23. PubMed ID: 8018762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influence of tumor necrosis factor-alpha and interferon-gamma on erythropoietin production and erythropoiesis in cancer patients with anemia].
    Wang W; Zhang MH; Yu Y; Xu CG
    Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):681-4. PubMed ID: 18399174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin.
    Beguin Y; Clemons GK; Pootrakul P; Fillet G
    Blood; 1993 Feb; 81(4):1067-76. PubMed ID: 8427988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin production in patients with malignant lymphoma.
    Kostova G; Siljanovski N
    Prilozi; 2005 Dec; 26(2):157-68. PubMed ID: 16400237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inadequate erythropoietin production (epo) in patients with multiple myeloma].
    Kostova G; Siljanovski N
    Prilozi; 2004; 25(1-2):53-66. PubMed ID: 15735535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anemia in children with cancer is associated with decreased erythropoietic activity and not with inadequate erythropoietin production.
    Corazza F; Beguin Y; Bergmann P; André M; Ferster A; Devalck C; Fondu P; Buyse M; Sariban E
    Blood; 1998 Sep; 92(5):1793-8. PubMed ID: 9716610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressed serum erythropoietin response to anemia and the efficacy of recombinant erythropoietin in the anemia of rheumatoid arthritis.
    Takashina N; Kondo H; Kashiwazaki S
    J Rheumatol; 1990 Jul; 17(7):885-7. PubMed ID: 2213753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced serum levels of immunoreactive erythropoietin in patients with cirrhosis and chronic anemia.
    Siciliano M; Tomasello D; Milani A; Ricerca BM; Storti S; Rossi L
    Hepatology; 1995 Oct; 22(4 Pt 1):1132-5. PubMed ID: 7557862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoiesis and erythropoietin in multiple myeloma.
    Beguin Y
    Leuk Lymphoma; 1995 Aug; 18(5-6):413-21. PubMed ID: 8528047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating anemia associated with chronic renal failure with erythropoiesis stimulators: recombinant human erythropoietin might be the best among the available choices.
    Trkulja V
    Med Hypotheses; 2012 Jan; 78(1):157-61. PubMed ID: 22078846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum erythropoietin and erythropoiesis in high- and low-fetal hemoglobin beta-thalassemia intermedia patients.
    Galanello R; Barella S; Turco MP; Giagu N; Cao A; Dore F; Liberato NL; Guarnone R; Barosi G
    Blood; 1994 Jan; 83(2):561-5. PubMed ID: 7506955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum erythropoietin in patients with myelofibrosis with myeloid metaplasia.
    Barosi G; Liberato LN; Guarnone R
    Br J Haematol; 1993 Mar; 83(3):365-9. PubMed ID: 8485043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin production and erythropoiesis in compensated and anaemic states of hereditary spherocytosis.
    Guarnone R; Centenara E; Zappa M; Zanella A; Barosi G
    Br J Haematol; 1996 Jan; 92(1):150-4. PubMed ID: 8562388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anemia associated with advanced prostatic adenocarcinoma: effects of recombinant human erythropoietin.
    Beshara S; Letocha H; Linde T; Wikström B; Sandhagen B; Nilsson S; Danielson BG
    Prostate; 1997 May; 31(3):153-60. PubMed ID: 9167766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacodynamic analysis of erythropoiesis in preterm infants for determining the anemia treatment potential of erythropoietin.
    Saleh MI; Nalbant D; Widness JA; Veng-Pedersen P
    Am J Physiol Regul Integr Comp Physiol; 2013 May; 304(9):R772-81. PubMed ID: 23485870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietic agents and the elderly.
    Agarwal N; Prchal JT
    Semin Hematol; 2008 Oct; 45(4):267-75. PubMed ID: 18809098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin and the anemia of cancer.
    Beguin Y
    Acta Clin Belg; 1996; 51(1):36-52. PubMed ID: 8669161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interrelationship between erythropoietin and erythropoiesis: insights from renal transplantation.
    Lee DB
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):54-6. PubMed ID: 1928080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic value of serum erythropoietin levels].
    Gidáli J; Fehér I
    Orv Hetil; 1999 Feb; 140(8):411-5. PubMed ID: 10083814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum erythropoietin levels in several diseases].
    Rhyner K; Egli F; Niemöller M; Wieczorek A; Greminger P; Vetter W
    Nephron; 1989; 51 Suppl 1():39-46. PubMed ID: 2915782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.